Aller au Contenu
-
Chételat, G. La neuro-imagerie au service de la maladie d’Alzheimer. Med Sci (Paris) 27, 193–198 (2011).
-
Chételat, G. et al. Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer’s disease. YNICL 2, 356–365 (2013).
-
Imagerie moléculaire des dépôts beta-amyloïdes dans la maladie d’Alzheimer – Une décennie de recherche clinique. Article soumis à la Lettre du Neurologue, 2016.
-
Besson, F. L. et al. Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer’s Disease. J. Neurosci. 35, 10402–10411 (2015).
-
Chételat, G. Alzheimer disease: Aβ-independent processes-rethinking preclinical AD. Nature Publishing Group 9, 123–124 (2013).
-
Villemagne, V. L. & Chételat, G. Neuroimaging biomarkers in Alzheimer’s disease and other dementias. Ageing Research Reviews (2016).
-
Jack, C. R. et al. Suspected non-Alzheimer disease pathophysiology — concept and controversy. Nat Rev Neurol 12, 117–124 (2016).
-
La Joie, R. et al. Intrinsic connectivity identifies the hippocampus as a main crossroad between Alzheimer’s and semantic dementia-targeted networks. Neuron 81, 1417–1428 (2014).
